Filing Details

Accession Number:
0001209191-19-048913
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-09 16:52:41
Reporting Period:
2019-09-06
Accepted Time:
2019-09-09 16:52:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1262104 Mei Pharma Inc. MEIP Pharmaceutical Preparations (2834) 510407811
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1371859 Anna Christine White C/O Mei Pharma, Inc.
3611 Valley Centre Drive, Suite 500
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-06 15,000 $1.74 15,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The shares purchased by the reporting person are held through an Individual Retirement Account.
  2. The weighted average purchase price for the transaction reported was $1.7383, and the range of prices was between $1.725 and $1.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.